Former US head of Leo Pharma gets board seat at Kempharm
![](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/14643507/hwx9r6/ALTERNATES/schema-16_9/kempharm.jpg)
Biotech firm Kempharm has made space for the former President and CEO of Leo Pharma in the US, Christopher Posner, at its board table, the firm announces in a stock exchange notification.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Orphazyme CEO on sale: "It’s sad, but we tried everything"
For subscribers